Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Mavoglurant by Stalicla for Alcohol Dependence: Likelihood of Approval
Mavoglurant is under clinical development by Stalicla and currently in Phase II for Alcohol Dependence. According to GlobalData, Phase II...